Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria.
Souza MC, Pádua TA, Torres ND, Souza Costa MF, Candéa AP, Maramaldo T, Seito LN, Penido C, Estato V, Antunes B, Silva L, Pinheiro AA, Caruso-Neves C, Tibiriçá E, Carvalho L, Henriques MG.
Souza MC, et al. Among authors: torres nd.
Int Immunopharmacol. 2015 Feb;24(2):400-407. doi: 10.1016/j.intimp.2014.12.033. Epub 2015 Jan 7.
Int Immunopharmacol. 2015.
PMID: 25576659
Free article.